Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sunshine on the FDA
Motley Fool
Thursday, September 20, 2012 - 11:18am
tags:
FDA, drug approvals, advisory panels
2 Big Events For Obesity Drugmakers
Motley Fool
Thursday, September 20, 2012 - 11:10am
tags:
obesity, Arena Pharmaceuticals, Vivus, Qsymia, Belviq
Celgene's Drug Pipeline News Soothes Investor Worries
Investors.com
Thursday, September 20, 2012 - 11:01am
tags:
Celgene, psoriatic arthritis, Revlimid, apremilast
FDA Makes This Biotech Less Risky
Motley Fool
Thursday, September 20, 2012 - 10:59am
tags:
FDA, Ariad Pharmaceuticals
Sanofi: A Long-Term Winner On These FDA Approvals
Seeking Alpha
Thursday, September 20, 2012 - 10:58am
tags:
Sanofi, FDA, Aubagio, Zaltrap
10 drugmakers team up to improve testing process
Yahoo/AP
Thursday, September 20, 2012 - 10:38am
tags:
TransCelerate BioPharma, Pfizer, JNJ, Bristol-Myers Squibb, Eli Lilly, Abbott Laboratories, GSK, AstraZeneca, Sanofi, Boehringer Ingelheim, Genentech
Horizon Pharma plans offering of stock, warrants
Yahoo/AP
Thursday, September 20, 2012 - 10:30am
tags:
Horizon Pharma, stock offering
Glaxo Aims to Expand Synflorix Label
Yahoo/Zacks
Wednesday, September 19, 2012 - 11:51am
tags:
GSK, Synflorix, Theravance, streptococcus pneumoniae, vaccines
Valeant announces $1.75 bln debt offering to fund Medicis deal
Reuters
Wednesday, September 19, 2012 - 11:45am
tags:
Medicis, Valeant Pharmaceuticals, M&A
Lundbeck to stop making cancer drug Elspar
Fierce Pharma
Wednesday, September 19, 2012 - 11:43am
tags:
Lundbeck, Elspar, leukemia
NPSP Begins Run-Up into FDA Advisory Panel, Approval
Yahoo/Reuters
Wednesday, September 19, 2012 - 11:41am
tags:
FDA, advisory panels, NPS Pharmaceuticals, short bowel syndrome, Gattex
Questcor plunges 42% on drug reimbursement worries
Marketwatch
Wednesday, September 19, 2012 - 11:31am
tags:
Questcor, Aetna, Acthar
Achillion Back On The Hep C Roller Coaster Of Love
Seeking Alpha
Wednesday, September 19, 2012 - 11:30am
tags:
Achillion, hepatitis C, Abbott Labs, Gilead, JNJ, Merck, Pfizer, ACH-1625
Synergy Pharmaceuticals: Positioning For Pipeline Payoff
Seeking Alpha
Wednesday, September 19, 2012 - 11:14am
tags:
Synergy Pharmaceuticals, plecanatide, chronic idiopathic constipation, Ironwood
Drug Companies’ Lobbyist May Push to Expand U.S. Payments
Bloomberg
Wednesday, September 19, 2012 - 11:12am
tags:
Medicare, PhRMA
Are Stroke Drugs Better Than Stents?
WSJ Online
Wednesday, September 19, 2012 - 11:02am
tags:
stroke, Abbott Labs, Boston Scientific, JNJ, Covidien
Dyax And ViroPharma: An Overview Of HAE Space
Seeking Alpha
Wednesday, September 19, 2012 - 10:58am
tags:
ViroPharma, Dyax, Cinryze, hereditary angiodema, Kalbitor
2 Biotech Stocks Making Waves
Motley Fool
Wednesday, September 19, 2012 - 10:55am
tags:
Targacept, Arena Pharmaceuticals, TC-5619, ADHD, Belviq
Obesity Drugs Gain Attention on FDA Backing for Therapies
Bloomberg
Wednesday, September 19, 2012 - 10:53am
tags:
FDA, obesity, Zafgen, beloranib, Arena Pharmaceuticals
Analyst expects growth from Abbott Laboratories after pharmaceutical business spun off
Yahoo/AP
Wednesday, September 19, 2012 - 10:51am
tags:
Abbott Labs, AbbVie

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.